Findings suggest more efforts are needed to boost uptake of new tools to protect against the leading cause of hospitalization in infants.
The new data reveal no notable safety or effectiveness issues.
The AAP recommends that all kids ages 6 to 23 months old be vaccinated against COVID, given that they are at highest risk for severe disease.
The CDC projects that COVID infections are growing or likely growing in most states.
The authors show how a relatively small serosurveillance scheme could complement traditional surveillance, enhancing epidemic understanding and forecast modeling.
For infants born from October to February, maternal vaccination was cost-effective, but nirsevimab was cost-effective only in those born in October and November.
Officials estimated that 228 fewer babies younger than 3 months older were hospitalized for serious RSV infection during the peak of the season, a number they hope will increase as more women are vaccinated.
The odds of a respiratory tract infection and any infection were lower in the SARS-CoV-2 group.
Adults 65 and older hospitalized for RSV had higher rates of poor outcomes like heart conditions, ICU admission, and 30-day mortality.
Among adults with RSV pneumonia, dementia was tied to the highest odds for ICU admission.
